Legend Biotech CorporationLEGNNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank46
3Y CAGR-62.5%
5Y CAGR-1.8%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-62.5%/yr
vs +522.0%/yr prior
5Y CAGR
-1.8%/yr
Recent deceleration
Acceleration
-584.6pp
Decelerating
Percentile
P46
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 6.77% |
| Q2 2025 | 30.76% |
| Q1 2025 | 4.57% |
| Q4 2024 | 16.43% |
| Q3 2024 | -14.11% |
| Q2 2024 | 98.45% |
| Q1 2024 | 18.28% |
| Q4 2023 | -17.24% |
| Q3 2023 | 30.93% |
| Q2 2023 | 101.81% |
| Q1 2023 | 31.49% |
| Q4 2022 | 0.99% |
| Q3 2022 | 128.56% |
| Q2 2022 | -71.04% |
| Q1 2022 | 5.99% |
| Q4 2021 | 128.88% |
| Q3 2021 | -18.23% |
| Q2 2021 | 45.65% |
| Q1 2021 | -65.28% |
| Q4 2020 | 230.63% |
| Q3 2020 | 7.42% |
| Q2 2020 | -8.35% |
| Q1 2020 | -40.11% |
| Q4 2019 | 19.57% |
| Q3 2019 | 75.22% |
| Q2 2019 | 0.34% |
| Q1 2019 | 0.00% |